Evanthia Bernitsas, MD, of the Department of Neurology at Wayne State University School of Medicine, gives an overview of neuromyelitis optica spectrum disorder (NMOSD) and discusses how the disease affects certain race populations differently.
As Dr. Bernitsas explains, NMOSD is a rare central nervous disorder that primarily affects the spinal cord and optic nerves. Symptoms of NMOSD may include blindness in one or both eyes, weakness or paralysis of arms or legs, spasming, loss of sensation, uncontrollable vomiting and hiccups, and bladder/bowel problems due to spinal cord damage.
Dr. Bernitsas also explains that African American NMOSD patients often have an earlier age of onset and more severe relapses compared to Caucasian patients.
Recently, results of a retrospective analysis of the pivotal Phase 2/3 N-MOmentum clinical trial were announced that indicate inebilizumab may provide durable efficacy and a favorable safety profile for African Americans with NMOSD.
To learn more about NMOSD and other neurological disorders, visit checkrare.com/diseases/neurology
